novartis glp 1 Readout Newsletter: Sage, Sanofi, Novartis, Novovax news novartis glp-1 receptor agonist weight

For weight management, NICE technology appraisals TA875 (semaglutide/Wegovy) and TA664 (liraglutide/Saxenda) specify that treatment must be initiated within specialist weight management services, with specific BMI thresholds and time-limited treatment periods

How MeAgain Turns Food Noise Into Something You Can See 01A Food Noise Slider, By Name Most trackers make you invent a workaround for the thing GLP-1 users talk about most

The group that took the placebo only lost an average of 2.4% of their body weight, while the group that took semaglutide lost over 14% of theirs

doi: 10.1001/jamainternmed.2013.2720 221 KnapenLMvan DalemJKeulemansYCvan ErpNPBazelierMTDe BruinMLet al

The larger concern during breastfeeding is not drug exposure, but reduced calorie and nutrient intake due to appetite suppression

Obese individuals may require doses at the higher end of the range, though this should be done under medical supervision